CRYSTALLINE FORMS OF OLAPARIB AND MANUFACTURING PROCESSES THEREFOR

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

15405155

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

In certain aspects, the invention provides crystalline forms of olaparib (4-[(3-[(4-cyclopropylcarbonyl)piperazin-4-yl]carbonyl)-4-fluorophenyl]methyl(2H)phthalazin-1-one). In related aspects, the invention provides processes for preparing the crystalline forms of olaparib. The processes include: forming a solution comprising crude olaparib and an organic solvent; adding an anti-solvent to the solution to form a slurry comprising a precipitate; isolating the precipitate; and drying the precipitate to obtain a crystalline form I of olaparib or a crystalline form II of olaparib.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SCINOPHARM TAIWAN LTDNO 1 NAN-KE 8TH ROAD SOUTHERN TAIWAN SCIENCE PARK SHAN-HUA TAINAN 74144

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hu, Tsung-Cheng Shan-Hua, TW 15 15
Huang, Yuan-Chang Shan-Hua, TW 72 757
Lin, Wen-Wei Shan-Hua, TW 38 115

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation